Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-09-15
1980-02-05
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424319, 424330, A61K 3124, A61K 31135, A61K 31195
Patent
active
041873173
ABSTRACT:
Compositions for treating radiation induced erythemas and for protecting the human skin against the harmful effects of sunlight, containing as the active ingredient N-benzylideneaniline and its derivatives.
REFERENCES:
patent: 3833606 (1974-09-01), Mohan
patent: 3862833 (1975-01-01), Johnson
patent: 3947587 (1976-03-01), Negrevergne
patent: 3993645 (1976-11-01), Crouse et al.
patent: 4047803 (1977-09-01), Yaguchi
patent: 4122026 (1978-10-01), Osman
Kadaba et al., J. Heter. Chem., vol. 4, pp. 301-304 (1967).
Goetz, J. Heter. Chem., vol. 5, pp. 501-507 (1968).
Bellobono et al., Tetrahedron, vol. 25, pp. 57-71 (1969).
Pavini et al., Gazz. Chem. Ital., vol. 96, pp. 1423-1431 (1966).
Ogata et al., J. Chem. Soc., Perkin Trans., vol. 2, pp. 792-797 (1972).
Douglas George H.
Nuss, Jr. George W.
Santora Norman J.
Friedman Stanley J.
William H. Rorer, Inc.
LandOfFree
Sunscreen and erythema treating with N-benzylidene anilenes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sunscreen and erythema treating with N-benzylidene anilenes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sunscreen and erythema treating with N-benzylidene anilenes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2180666